TORONTO, May 13, 2014 (Canada NewsWire via COMTEX) -- Transition Therapeutics Inc. ("Transition" or the "Company") /quotes/zigman/39571/realtime CA:TTH +5.63% /quotes/zigman/39565/delayed/quotes/nls/tthi TTHI +5.62% , a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the three and nine month periods ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
